Roy D. Baynes - 19 Nov 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
19 Nov 2025
Net transactions value
-$2,284,766
Form type
4
Filing time
21 Nov 2025, 20:05:05 UTC
Previous filing
04 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baynes Roy D. Director C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN /s/ Vincent Fontanilla, Attorney-in-Fact 21 Nov 2025 0001680739

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $209,234 +5,112 +28% $40.93 23,471 19 Nov 2025 Direct
transaction NTRA Common Stock Sale $266,839 -1,250 -5.3% $213.47 22,221 19 Nov 2025 Direct F1, F2
transaction NTRA Common Stock Sale $370,946 -1,727 -7.8% $214.79 20,494 19 Nov 2025 Direct F1, F3
transaction NTRA Common Stock Sale $461,304 -2,135 -10% $216.07 18,359 19 Nov 2025 Direct F1, F4
transaction NTRA Common Stock Options Exercise $24,558 +600 +3.3% $40.93 18,959 20 Nov 2025 Direct
transaction NTRA Common Stock Options Exercise $291,131 +7,068 +37% $41.19 26,027 20 Nov 2025 Direct
transaction NTRA Common Stock Sale $260,646 -1,184 -4.5% $220.14 24,843 20 Nov 2025 Direct F1, F5
transaction NTRA Common Stock Sale $199,632 -900 -3.6% $221.81 23,943 20 Nov 2025 Direct F1, F6
transaction NTRA Common Stock Sale $401,220 -1,800 -7.5% $222.90 22,143 20 Nov 2025 Direct F1, F7
transaction NTRA Common Stock Sale $425,417 -1,900 -8.6% $223.90 20,243 20 Nov 2025 Direct F1, F8
transaction NTRA Common Stock Sale $423,685 -1,884 -9.3% $224.89 18,359 20 Nov 2025 Direct F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -5,112 -89% $0.000000 600 19 Nov 2025 Common Stock 5,112 $40.93 Direct F10
transaction NTRA Stock Option (right to buy) Options Exercise $0 -600 -100% $0.000000 0 20 Nov 2025 Common Stock 600 $40.93 Direct F10
transaction NTRA Stock Option (right to buy) Options Exercise $0 -7,068 -100% $0.000000 0 20 Nov 2025 Common Stock 7,068 $41.19 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.18 to $214.1550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.35 to $215.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.55 to $216.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.46 to $223.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.49 to $224.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.72 to $224.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The option shares are fully exercisable.